Page: 18 of 30 14 15 16 17 18 19 20 21 22

Dr Kimberly Blackwell - Duke University Medical Center, USA Channel: www.ecancer.tv Length: 0 Date: January 28, 2010 Two targeted therapies - lapatinib plus trastuzumab - are better than one in the fight against HER2-positive metastatic breast cancer. These two t...

Prof Richard Sullivan - King’s College London Channel: www.ecancer.tv Length: 0 Date: January 28, 2010 Professor Richard Sullivan, from the King’s Health Partners Integrated Cancer Centre at King's College London and former head of clinical...

Dr Rajeshwar Rao Tekmal - University of Texas Health Science Center, San Antonio, USA Channel: www.ecancer.tv Length: 0 Date: January 28, 2010 Treating oestrogen receptor-positive breast cancer tumours with a combination of fidarestat (an inhibitor of aldose reductase enzyme) and letrozole...

Prof Nigel Bundred - University of Manchester, UK Channel: www.ecancer.tv Length: 0 Date: January 28, 2010 Preoperative combination therapy with letrozole and zoledronic acid is safe and effective, but more research is needed to verify the impact on ove...

Prof William Gradishar - Robert H. Lurie Comprehensive Cancer Center, USA Channel: www.ecancer.tv Length: 0 Date: January 28, 2010 Combining chemotherapy with a drug widely used to treat liver and kidney cancer has offered advanced breast cancer patients with HER2-negative tumo...

Dr Angelo Di Leo - Hospital of Prato, Italy Channel: www.ecancer.tv Length: 0 Date: January 28, 2010 A higher dose of fulvestrant is well tolerated and more active than the standard, lower dose in postmenopausal patients with advanced breast cance...

Prof Theresa Guise - Indiana University School of Medicine, USA Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 Prof Theresa Guise discusses bone micro-environment and cancer, looking at the interaction of tumour cells and osteoclasts.

Prof Edith Perez - Mayo Clinic, Florida, USA Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 www.ecancer.tv

Dr Meredith Regan - Dana-Farber Cancer Institute, Boston, USA Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 Dr Meredith Regan talks about the BIG 1-98 trial, looking at different strategies for endocrine therapy in post-menopausal women with early breast...

Prof Michelle Holmes - Harvard Medical School, USA Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 Prof Michelle Holmes talks about how life style factors effect survival of breast cancer patients such as obesity and alcohol consumption.

Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital, Italy Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 Dr Angelo Di Leo talks about a Phase III clinical trial comparing two different doses of fulvestrant in the treatment of breast cancer.

Prof Quentin Pankhurst and Dr Michael Douek - University College London, UK Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 Prof Quentin Pankhurst and Dr Michael Douek discuss a new technique to perform sentinel lymph node biopsy, using a handheld magnetometer.

Dr Laura Van’t Veer - The Netherlands Cancer Institute, Amsterdam, The Netherlands Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 Dr Laura Van’t Veer looks at the biology of tumours and to understand gene activity in order to find out which patients will respond to what therap...

Dr Valerie Beral - University of Oxford, UK Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 Dr Valerie Beral discusses the causes of breast cancer and how it might be prevented it. She also talks about the differences in breast cancer rate...

Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 Dr Gordon Mills discusses the need to apply new proteomic technologies to improve patient management.

Dr Teru Hideshima - Principal Associate in Medicine, Harvard Medical School Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 Dr Teru Hideshima talks about a new protein, B-Cell Lymphoma 6, as a possible new target for myeloma.

Dr Tyler Curiel - University of Texas Health Science Center, San Antonio, USA Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 New paradigms in tumour immunotherapyDr Tyler Curiel discusses research about immune based therapy and the issues compared with other therapies.

Dr Mathias Rummel - University Hospital, Giessen, Germany Channel: www.ecancer.tv Length: 0 Date: January 27, 2010 www.ecancer.tv

Prof Gordon McVie - ecancer managing editor Channel: www.ecancer.tv Length: 0 Date: January 20, 2010 ecancer round up of the multiple myeloma news to come out of the American Society of Hematology meeting in New Orleans 5-8th December 2009.

Prof Gordon McVie - European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: January 18, 2010 American Society of Haematology Meeting, New Orleans, 5-9th December 2009. ecancer Managing Editor Gordon McVie gives his roundup of ASH 2009 news...

Page: 18 of 30 14 15 16 17 18 19 20 21 22